You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 10, October 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cerebrovascular Disease
 •Stroke
 •Women's Health
 •Women's Health, Other
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Stroke Risk, Hypertension, and HRTless Postmenopausal Therapy

Arch Neurol. 2003;60:1363-1364.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

RESULTS OF A STUDY by Løkkegaard et al1 in this month's ARCHIVES suggest that particular caution be given to the prescription of hormone therapy (HRT) to hypertensive postmenopausal women, at least in terms of increased risk for stroke. This study addressed stroke risk during a 5-year period in 13 122 healthy postmenopausal women who participated in the Danish Nurse Cohort Study.2 Participants were studied by means of an initial questionnaire, and outcomes, by means of periodic sampling of the National Patient Registry of Hospital Discharges, which registers all hospital admissions in Denmark. The salient finding of the Løkkegaard study is that although no risk for total stroke was found with HRT use, there was significant 5-year hazard with the use of combined HRT in hypertensive women for ischemic stroke (hazard ratio, 5.01; 95% CI, 2.09-12.00). The study also noted lesser hazard for uncombined estradiol use in ischemic stroke and for combined . . . [Full Text of this Article]

Douglas A. Dulli, MD, MS
Department of Neurology
University of Wisconsin Medical School
Clinical Science Center H6/574
600 Highland Ave
Madison, WI 53792
(e-mail: dulli@neurology.wisc.edu)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Increased Risk of Stroke in Hypertensive Women Using Hormone Therapy: Analyses Based on the Danish Nurse Study
Ellen Løkkegaard, Zorana Jovanovic, Berit L. Heitmann, Niels Keiding, Bent Ottesen, Yrsa Andersen Hundrup, Erik B. Obel, and Annette Tønnes Pedersen
Arch Neurol. 2003;60(10):1379-1384.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuronal activity in the globus pallidus internus in patients with tics
Zhuang et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:1075-1081.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.